Boston-based Immunovia is a leader in the emerging field of early cancer detection, revolutionizing blood-based diagnostics and increasing survival rates for people with pancreatic cancer.

 

RMC provides insight into Immunovia’s success through social and earned media, as well as content creation for the company’s U.S. business.